Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-07 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.21 | 5e-06 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |